Jennell Bilek, PharmD, PhD, JD

Adjunct Assistant Professor, Department of Pharmaceutical Care & Health Systems

Jennell Bilek

Contact Info

Office Phone 612-436-9648

Office Address:
225 S. 6th St Suite 4200, Minneapolis, MN 55402

Mailing Address:
225 S. 6th St Suite 4200, Minneapolis, MN 55402

PharmD, University of Minnesota

PhD, Social & Administrative Pharmacy, University of Minnesota

BS, Journalism, Iowa State

Juris Doctorate (JD), Mitchell Hamline School of Law


Jennell co-directs the pharmacy law course for the College of Pharmacy. She is an equity partner at the Twin Cities based law firm, Carlson Caspers. Jennell counsels clients and tries complex lawsuits in a variety of industries with a passion for health care. She has served as trial counsel in the U.S. District Court for the District of Delaware and Southern District of New York, and as counsel for many lawsuits that have settled prior to trial. She focuses her law practice on intellectual property (patents, trade secrets, trademarks) and health care litigation. Prior to becoming an attorney, Jennell worked as a retail pharmacist and co-founded a pharmacy benefit consulting company where she counseled large employers during implementation of their first drug formularies and pharmacy benefit management strategies. She also assisted a pharmaceutical market expert with lawsuits relating to pharmaceutical pricing, antitrust, the Hatch Waxman Act, and misappropriations of trade secrets.


Research Summary/Interests

  • Intellectual property (patent, trade secret, and trademark)
  • Regulation of prescription, OTC, and compounded drug products 
  • Health care fraud and compliance
  • Publications

    Bilek JC, The Relationship Between Overall Utilization and Settlements Involving Off-Label Promotion of Prescription Drugs, Ph.D. Dissertation (2013). 

    Bilek JC, Antitrust and the Pharmacist-Patient Relationship, 45 JAPHA 290 (2005). 

    Bilek JC, Sepulveda D, Schondelmeyer SW. Comparative Analyses of Drug Treatment Costs between Therapeutically Similar Alternatives. American Pharmacist Association (APhA) Annual Meeting Supplemental Symposium Proceedings (2005). 

    Bilek JC, Carlson AM, Morris LS. Prescribing Trends for Combination Products in the Treatment of Type II Diabetes. International Society for Pharmacoeconomics and Outcomes Research Annual Meeting Supplemental Symposium Proceedings (2005). 

    Schwartzman DS, Bilek JC, Harvey M, Hoyt RH, Kohler J, Ujhelyi MR. Does Ambulatory 600 mg Oral Propafenone Benefit Patients Managed with Implantable Atrial Defibrillation Therapy? 26(4p2) PACING AND CLINICAL ELECTROCARDIOLOGY 929 (2003).



    PHAR 6778